Genetic Technologies
GENE
#10485
Rank
NZ$6.41 M
Marketcap
NZ$1.32
Share price
0.00%
Change (1 day)
-68.35%
Change (1 year)

Genetic Technologies (GENE) - P/B ratio

P/B ratio as of December 2025 : 3.03

According to Genetic Technologies's latest financial reports the company has a price-to-book ratio of 0.216814.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Genetic Technologies - P/B ratio (from 2004 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-313.03-9.28%
2023-12-313.3438.3%
2022-12-312.411.73%
2021-12-312.37-33.09%
2020-12-313.54-54.6%
2019-12-317.8148.57%
2018-12-315.2521.93%
2017-12-314.31234.77%
2016-12-311.29-52.01%
2015-12-312.68-93.62%
2014-12-3142.1857.32%
2013-12-314.3945.88%
2012-12-313.01-13.32%
2011-12-313.47162.07%
2010-12-311.33-16.69%
2009-12-311.5953.47%
2008-12-311.04-54.92%
2007-12-312.30-55.79%
2006-12-315.2013.23%
2005-12-314.5931.87%
2004-12-313.48

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Eterna Therapeutics
ERNA
2.86-5.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
1.77-41.60%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
2.48-18.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
2.76-8.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
3.33 9.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
3.15 3.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
4.17 37.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
0.6195-79.53%๐Ÿ‡บ๐Ÿ‡ธ USA